Kamada (KMDA) Reports In-Line Q2 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Kamada Reports Financial Results for the Second Quarter and First Six Months of 2016
August 2, 2016 6:30 AM EDTTotal Revenues for First Half of 2016 Grew 20% to $33.9 Million vs. First Half of 2015
Proprietary Products Revenue Grew 46% to $23.2 Million in First Half of 2016 vs. First Half of 2015
Company Reiterates 2016 Revenue Guidance and 2017 Sales Target of $100 Million
Conference Call Today at 8:30am Eastern Time
NESS ZIONA, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced financial results for the three and... More
